𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasminogen activator inhibitors in endometrial adenocarcinoma

✍ Scribed by Noreen C. Gleeson; Rohini Gonsalves; J. Bonnar

Book ID
101333283
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
277 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Urokinase plasminogen activator and urok
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
✍ C. Duggan; T. Maguire; E. McDermott; N. O'Higgins; J. J. Fennelly; M. J. Duffy πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 385 KB πŸ‘ 1 views

Urokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA mediates its action while attached to a membrane-bound receptor (uPAR). In this investigation we show that uPAR levels correlate with uPA levels in human breast cancers. uPAR levels, however, d

Expression of plasminogen activators and
Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma
✍ Carsten HΓ€ckel; Bogdan Czerniak; Alberto G. Ayala; Kathrin Radig; Albert Roessne πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 474 KB πŸ‘ 1 views

## Background: The plasminogen activator system plays an important role in different malignant tumors. these enzymes participate in the destruction of intercellular matrices and basement membranes and/or can modulate the growth potency of tumor cells and may even promote metastases. in this study,